Drug
Who makes disopyramide phosphate?
4 companies list disopyramide phosphate as a human prescription drug, including under the names Norpace, Norpace CR. Forms: capsule; capsule, extended release; capsule, gelatin coated. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing disopyramide phosphate
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | capsule, extended release; capsule, gelatin coated | NDANDA017447, NDA018655 | 4 | 0 |
| Teva Pharmaceutical Industries Ltd.Canada | capsule | ANDAANDA070101, ANDA070102 | 2 | 6 |
| Dr. Reddy's Labratories Inc. | capsule | ANDAANDA070173 | 2 | 0 |
| Mylan Pharmaceuticals, Inc. | capsule, gelatin coated | NDA AUTHORIZED GENERICNDA017447 | 2 | 0 |
Bulk ingredient listings
- Archimica S.p.A.Italy · 1 NDC
- PCAS Finland OyFinland · 1 NDC
- Sumitomo Chemical Company, LimitedJapan · 1 NDC
Enquiry
Common questions
- Who makes disopyramide phosphate?
- 4 companies list disopyramide phosphate as a human prescription drug in the openFDA NDC Directory, led by Pfizer Laboratories Div Pfizer Inc, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Labratories Inc., Mylan Pharmaceuticals, Inc.. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Is there a generic Norpace?
- 2 companies list disopyramide phosphate under an abbreviated new drug application (ANDA), the application type used for generics, and 1 under an NDA or BLA. Listing status is from the NDC Directory; it is not a statement of availability.
- Who supplies disopyramide phosphate active ingredient?
- 3 companies list disopyramide phosphate as a bulk ingredient, including Archimica S.p.A., PCAS Finland Oy, Sumitomo Chemical Company, Limited.